Mr. Barry Fishman reports

ABCANN GLOBAL ANNOUNCES RECEIPT OF HEALTH CANADA LICENSE TO PRODUCE CANNABIS OILS

ABcann Global Corp. has been licensed by Health Canada to produce medical cannabis oils. Once ABcann has saleable extracted finished products, Health Canada will conduct a final inspection to approve the sale of cannabis oils by the company. This is expected in the first quarter of 2018.

"Receipt of the licence to produce cannabis oils is a major milestone in our pursuit to provide our medical cannabis patients with additional product formats that can be precisely dosed," commented Barry Fishman, chief executive officer of ABcann. "The expansion and innovation of our product lines are a top priority for the company as we continue to serve the needs of our customers, and we anticipate strong demand for our cannabis oil products."

About ABcann Global Corp.

ABcann holds production and sales licences from Health Canada. Its flagship facility in Napanee, Ont., contains proprietary plant-growing technology, centred on its specially designed, environmentally controlled growing chambers.

The company is expanding its cultivation capacity and pursuing partnership and product development opportunities domestically as well as in select international markets such as Germany, Australia and Israel.

We seek Safe Harbor.